Hafnium Targets
Hafnium Targets market is segmented by region (country), players, by Type and by Application. Pla ... Read More
Global and United States Haemostat Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Haemostat Product Introduction
1.2 Global Haemostat Outlook 2017 VS 2022 VS 2028
1.2.1 Global Haemostat Sales in US$ Million for the Year 2017-2028
1.2.2 Global Haemostat Sales in Volume for the Year 2017-2028
1.3 United States Haemostat Outlook 2017 VS 2022 VS 2028
1.3.1 United States Haemostat Sales in US$ Million for the Year 2017-2028
1.3.2 United States Haemostat Sales in Volume for the Year 2017-2028
1.4 Haemostat Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Haemostat in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Haemostat Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Haemostat Market Dynamics
1.5.1 Haemostat Industry Trends
1.5.2 Haemostat Market Drivers
1.5.3 Haemostat Market Challenges
1.5.4 Haemostat Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Haemostat Market Segment by Type
2.1.1 Pituitrin
2.1.2 Hemostatic Sensitivity
2.1.3 Others
2.2 Global Haemostat Market Size by Type
2.2.1 Global Haemostat Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Haemostat Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Haemostat Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Haemostat Market Size by Type
2.3.1 United States Haemostat Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Haemostat Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Haemostat Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Haemostat Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 ASCs
3.1.4 Others
3.2 Global Haemostat Market Size by Application
3.2.1 Global Haemostat Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Haemostat Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Haemostat Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Haemostat Market Size by Application
3.3.1 United States Haemostat Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Haemostat Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Haemostat Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Haemostat Competitor Landscape by Company
4.1 Global Haemostat Market Size by Company
4.1.1 Top Global Haemostat Manufacturers Ranked by Revenue (2021)
4.1.2 Global Haemostat Revenue by Manufacturer (2017-2022)
4.1.3 Global Haemostat Sales by Manufacturer (2017-2022)
4.1.4 Global Haemostat Price by Manufacturer (2017-2022)
4.2 Global Haemostat Concentration Ratio (CR)
4.2.1 Haemostat Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Haemostat in 2021
4.2.3 Global Haemostat Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Haemostat Manufacturing Base Distribution, Product Type
4.3.1 Global Haemostat Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Haemostat Product Type
4.3.3 Date of International Manufacturers Enter into Haemostat Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Haemostat Market Size by Company
4.5.1 Top Haemostat Players in United States, Ranked by Revenue (2021)
4.5.2 United States Haemostat Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Haemostat Sales by Players (2020, 2021 & 2022)
5 Global Haemostat Market Size by Region
5.1 Global Haemostat Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Haemostat Market Size in Volume by Region (2017-2028)
5.2.1 Global Haemostat Sales in Volume by Region: 2017-2022
5.2.2 Global Haemostat Sales in Volume Forecast by Region (2023-2028)
5.3 Global Haemostat Market Size in Value by Region (2017-2028)
5.3.1 Global Haemostat Sales in Value by Region: 2017-2022
5.3.2 Global Haemostat Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Haemostat Market Size YoY Growth 2017-2028
6.1.2 North America Haemostat Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Haemostat Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Haemostat Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Haemostat Market Size YoY Growth 2017-2028
6.3.2 Europe Haemostat Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Haemostat Market Size YoY Growth 2017-2028
6.4.2 Latin America Haemostat Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Haemostat Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Haemostat Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Ethicon
7.1.1 Ethicon Corporation Information
7.1.2 Ethicon Description and Business Overview
7.1.3 Ethicon Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ethicon Haemostat Products Offered
7.1.5 Ethicon Recent Development
7.2 CSL Behring
7.2.1 CSL Behring Corporation Information
7.2.2 CSL Behring Description and Business Overview
7.2.3 CSL Behring Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.2.4 CSL Behring Haemostat Products Offered
7.2.5 CSL Behring Recent Development
7.3 Pfizer
7.3.1 Pfizer Corporation Information
7.3.2 Pfizer Description and Business Overview
7.3.3 Pfizer Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Haemostat Products Offered
7.3.5 Pfizer Recent Development
7.4 Equimedical BV
7.4.1 Equimedical BV Corporation Information
7.4.2 Equimedical BV Description and Business Overview
7.4.3 Equimedical BV Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Equimedical BV Haemostat Products Offered
7.4.5 Equimedical BV Recent Development
7.5 Davol
7.5.1 Davol Corporation Information
7.5.2 Davol Description and Business Overview
7.5.3 Davol Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Davol Haemostat Products Offered
7.5.5 Davol Recent Development
7.6 Baxter
7.6.1 Baxter Corporation Information
7.6.2 Baxter Description and Business Overview
7.6.3 Baxter Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Baxter Haemostat Products Offered
7.6.5 Baxter Recent Development
7.7 Hemcon Medical Technologies
7.7.1 Hemcon Medical Technologies Corporation Information
7.7.2 Hemcon Medical Technologies Description and Business Overview
7.7.3 Hemcon Medical Technologies Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Hemcon Medical Technologies Haemostat Products Offered
7.7.5 Hemcon Medical Technologies Recent Development
7.8 Ceremed
7.8.1 Ceremed Corporation Information
7.8.2 Ceremed Description and Business Overview
7.8.3 Ceremed Haemostat Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Ceremed Haemostat Products Offered
7.8.5 Ceremed Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Haemostat Industry Chain Analysis
8.2 Haemostat Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Haemostat Distributors
8.3 Haemostat Production Mode & Process
8.4 Haemostat Sales and Marketing
8.4.1 Haemostat Sales Channels
8.4.2 Haemostat Distributors
8.5 Haemostat Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Haemostat CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Haemostat Market Trends
Table 3. Haemostat Market Drivers
Table 4. Haemostat Market Challenges
Table 5. Haemostat Market Restraints
Table 6. Global Haemostat Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Haemostat Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Haemostat Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Haemostat Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Haemostat Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Haemostat Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Haemostat Revenue Share by Manufacturer, 2017-2022
Table 13. Global Haemostat Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Haemostat Sales Share by Manufacturer, 2017-2022
Table 15. Global Haemostat Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Haemostat Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Haemostat by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemostat as of 2021)
Table 18. Top Players of Haemostat in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Haemostat Product Type
Table 20. Date of International Manufacturers Enter into Haemostat Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Haemostat Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Haemostat Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Haemostat Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Haemostat Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Haemostat Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Haemostat Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Haemostat Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Haemostat Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Haemostat Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Haemostat Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Haemostat Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Haemostat Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Haemostat Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Haemostat Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Haemostat Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Haemostat Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Haemostat Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Haemostat Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Haemostat Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Haemostat Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Ethicon Corporation Information
Table 43. Ethicon Description and Business Overview
Table 44. Ethicon Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Ethicon Haemostat Product
Table 46. Ethicon Recent Development
Table 47. CSL Behring Corporation Information
Table 48. CSL Behring Description and Business Overview
Table 49. CSL Behring Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. CSL Behring Product
Table 51. CSL Behring Recent Development
Table 52. Pfizer Corporation Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Pfizer Product
Table 56. Pfizer Recent Development
Table 57. Equimedical BV Corporation Information
Table 58. Equimedical BV Description and Business Overview
Table 59. Equimedical BV Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Equimedical BV Product
Table 61. Equimedical BV Recent Development
Table 62. Davol Corporation Information
Table 63. Davol Description and Business Overview
Table 64. Davol Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Davol Product
Table 66. Davol Recent Development
Table 67. Baxter Corporation Information
Table 68. Baxter Description and Business Overview
Table 69. Baxter Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Baxter Product
Table 71. Baxter Recent Development
Table 72. Hemcon Medical Technologies Corporation Information
Table 73. Hemcon Medical Technologies Description and Business Overview
Table 74. Hemcon Medical Technologies Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Hemcon Medical Technologies Product
Table 76. Hemcon Medical Technologies Recent Development
Table 77. Ceremed Corporation Information
Table 78. Ceremed Description and Business Overview
Table 79. Ceremed Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Ceremed Product
Table 81. Ceremed Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Haemostat Customers List
Table 85. Haemostat Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemostat Product Picture
Figure 2. Global Haemostat Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Haemostat Market Size 2017-2028 (US$ Million)
Figure 4. Global Haemostat Sales 2017-2028 (K Units)
Figure 5. United States Haemostat Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Haemostat Market Size 2017-2028 (US$ Million)
Figure 7. United States Haemostat Sales 2017-2028 (K Units)
Figure 8. United States Haemostat Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Haemostat Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Haemostat Report Years Considered
Figure 11. Product Picture of Pituitrin
Figure 12. Product Picture of Hemostatic Sensitivity
Figure 13. Product Picture of Others
Figure 14. Global Haemostat Market Share by Type in 2022 & 2028
Figure 15. Global Haemostat Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Haemostat Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Haemostat Sales by Type (2017-2028) & (K Units)
Figure 18. Global Haemostat Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Haemostat Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Haemostat Market Share by Type in 2022 & 2028
Figure 21. United States Haemostat Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Haemostat Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Haemostat Sales by Type (2017-2028) & (K Units)
Figure 24. United States Haemostat Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Haemostat Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Hospital
Figure 27. Product Picture of Clinic
Figure 28. Product Picture of ASCs
Figure 29. Product Picture of Others
Figure 30. Global Haemostat Market Share by Application in 2022 & 2028
Figure 31. Global Haemostat Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Haemostat Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Haemostat Sales by Application (2017-2028) & (K Units)
Figure 34. Global Haemostat Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Haemostat Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Haemostat Market Share by Application in 2022 & 2028
Figure 37. United States Haemostat Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Haemostat Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Haemostat Sales by Application (2017-2028) & (K Units)
Figure 40. United States Haemostat Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Haemostat Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Haemostat Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Haemostat Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Haemostat Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Haemostat Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Haemostat Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Haemostat Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Haemostat Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Haemostat Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Haemostat Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Haemostat Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Haemostat Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Haemostat Value Chain
Figure 76. Haemostat Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ethicon CSL Behring Pfizer Equimedical BV Davol Baxter Hemcon Medical Technologies Ceremed